Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.

Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.

Item
http://www.wikidata.org/entity/Q36117785
Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121).Targeting epidermal growth factor receptor for head and neck squamous cell carcinoma: still lost in translation?Neuregulin expression in solid tumors: prognostic value and predictive role to anti-HER3 therapies.Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or -Refractory Ovarian Cancer.HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models.Treatment of head and neck cancer in the elderly.Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV+ Patients.ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC.Commentary: Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study).Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer.A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer.Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma.MiR-503 enhances the radiosensitivity of laryngeal carcinoma cells via the inhibition of WEE1.A correlative analysis of PD-L1, PD-1, PD-L2, EGFR, HER2, and HER3 expression in oropharyngeal squamous cell carcinoma.
P2860

Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.

Item
http://www.wikidata.org/entity/Q36117785
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
@ast
Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
@en
type
label
Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
@ast
Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
@en
prefLabel
Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
@ast
Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932